본문 바로가기

타이틀 타이틀

  • ABOUT
    • General Information
    • CEO Message
    • Organization
    • History
    • Global Network
    • Recruit
  • PRODUCT
    • Product
    • Trouble shooting
    • COA
    • Inquiry
    • Feedback
  • TECHNOLOGY
    • Platform
    • PIpeline
    • Application
    • Facility
  • KNOWLEDGE CENTRE
    • Trends
    • Publication
  • IR
    • 재무정보
    • 공시
    • 공고
  • PR
    • Notice
    • News
    • Xcell Story
    • Inquiry
  • EN
  • KR
검색
  • EN
  • KR

ABOUT

  • GENERAL INFORMATION
  • CEO MESSAGE
  • ORGANIZATION
  • HISTORY
  • GLOBAL NETWORK
  • Recruit

PRODUCT

  • PRODUCT
  • TROUBLE SHOOTING
  • COA
  • INQUIRY
  • FEEDBACK

TECHNOLOGY

  • PLATFORM
  • PIPELINE
  • APPLICATION
  • FACILITY

KNOWLEDGE
CENTRE

  • TRENDS
  • PUBLICATION

IR

  • FINANCIAL STATEMENT
  • DISCLOSURE
  • FINANCIAL STATEMENT

NOTICE

  • NOTICE
  • NEWS
  • Xcell Story
  • Inquiry

PR

  • Notice
  • News
  • Xcell Story
  • Inquiry

News

notice

첨단재생의료산업협회(CARM), 제1차 기업·기술교류회 성료

2022.05.04

(사진=CARM) 

http://www.biotimes.co.kr/news/articleView.html?idxno=7729 

PREV

엑셀세라퓨틱스, 국산 배지 최초 美·獨 수출...글로벌 공략 박차

NEXT

엑셀세라퓨틱스, 한국줄기세포학회와 업무협약 체결

서울특별시 강남구 영동대로 333 (대치동, 동원빌딩) 6층, 엑셀세라퓨틱스

  • TEL (+82-2) 863-1331
  • FAX 02-863-0832
  • E-MAIL xcell@xcell.co.kr

© 2020 Xcell Therapeutics Inc., Copyright

  • 개인정보처리방침